KD025,
911417-87-3,
SLx-2119,
KD-025,
KD025,
UNII-834YJF89WO,
SLx 2119,
KD025 (SLx-2119),
2-(3-(4-((1H-indazol-5-yl)amino)quinazolin-2-yl)phenoxy)-N-isopropylacetamide,
SLx2119,
834YJF89WO,
C26H24N6O2,
2-[3-[4-(1H-indazol-5-ylamino)quinazolin-2-yl]phenoxy]-N-propan-2-ylacetamide,
2-(3-(4-(1H-indazol-5-ylamino)quinazolin-2-yl)phenoxy)-N-isopropylacetamide,
2-[3-[4-[(1H-Indazol-5-yl)amino]quinazolin-2-yl]phenoxy]-N-isopropylacetamide,
ROCK inhibitor 2,
Kinome_2597,
SCHEMBL878202,
GTPL9558,
kd025-(slx-2119),
CHEMBL2005186,
DTXSID80238425,
GKHIVNAUVKXIIY-UHFFFAOYSA-N,
BDBM322155,
BCP15921,
EX-A2314,
4050AH,
KD 025,
MFCD23098791,
s7936,
ZINC63298464,
SLx-2119(KD-025),
SLx-2119; KD-025,
CS-0776,
SB16915,
Acetamide, 2-(3-(4-(1H-indazol-5-ylamino)-2-quinazolinyl)phenoxy)-N-(1-methylethyl)-,
NCGC00378903-01,
AK341023,
AS-35230,
HY-15307,
US10183931, SLx-2119,
KS-00000641,
W-5995,
2-(3-{4-[(1H-indazol-5-yl)amino]quinazolin-2-yl}phenoxy)-N-(propan-2-yl)acetamide,
ROCK Inhibitor,
KD-025 Free base,
CID11950170,
A3825,
A15239,
2-[3-[4-(1H-indazol-5-ylamino)quinazolin-2-yl]phenoxy]-N-propan-2-yl-acetamide,